User profiles for K. Ray

Kausik Kumar Ray

- Verified email at imperial.ac.uk - Cited by 163646

KP Ray, Kamla Prasan Ray

- Verified email at diat.ac.in - Cited by 8842

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the …

…, HN Ginsberg, I Graham, KK Ray… - European heart …, 2017 - academic.oup.com
Aims To appraise the clinical and genetic evidence that low-density lipoproteins (LDLs)
cause atherosclerotic cardiovascular disease (ASCVD). Methods and results We assessed …

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and …

…, A Corsini, GD Vladutiu, FJ Raal, KK Ray… - European heart …, 2015 - academic.oup.com
Statin-associated muscle symptoms (SAMS) are one of the principal reasons for statin non-adherence
and/or discontinuation, contributing to adverse cardiovascular outcomes. This …

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus …

…, JA Kuivenhoven, P Pajukanta, K Ray… - European heart …, 2013 - academic.oup.com
Aims The first aim was to critically evaluate the extent to which familial hypercholesterolaemia
(FH) is underdiagnosed and undertreated. The second aim was to provide guidance for …

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

KK Ray, SRK Seshasai, S Wijesuriya, R Sivakumaran… - The Lancet, 2009 - thelancet.com
Background Whether intensive control of glucose reduces macrovascular events and all-cause
mortality in individuals with type 2 diabetes mellitus is unclear. We undertook a meta-…

[HTML][HTML] Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

…, O Mosenzon, DK McGuire, KK Ray… - … England Journal of …, 2013 - Mass Medical Soc
Background The cardiovascular safety and efficacy of many current antihyperglycemic agents,
including saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, are unclear. Methods We …

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

…, JR Downs, H Nakamura, Y Ohashi, K Mizuno, KK Ray… - The Lancet, 2010 - thelancet.com
Background Trials of statin therapy have had conflicting findings on the risk of development
of diabetes mellitus in patients given statins. We aimed to establish by a meta-analysis of …

[HTML][HTML] Triglyceride lowering with pemafibrate to reduce cardiovascular risk

…, BG Nordestgaard, D Páll, KK Ray… - … England Journal of …, 2022 - Mass Medical Soc
Background High triglyceride levels are associated with increased cardiovascular risk, but
whether reductions in these levels would lower the incidence of cardiovascular events is …

Bempedoic acid and cardiovascular outcomes in statin-intolerant patients

…, AM Lincoff, D Brennan, KK Ray… - … England Journal of …, 2023 - Mass Medical Soc
Background Bempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein
(LDL) cholesterol levels and is associated with a low incidence of muscle-related adverse …

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

…, TR Pedersen, MJ Tikkanen, N Sattar, KK Ray - Jama, 2011 - jamanetwork.com
Context A recent meta-analysis demonstrated that statin therapy is associated with excess
risk of developing diabetes mellitus. Objective To investigate whether intensive-dose statin …

[BOOK][B] Broadband microstrip antennas

G Kumar, KP Ray - 2002 - books.google.com
… KP Ray is wholly dedicated to broadband microstrip antenna designs only. After the first
introductory chapter, there are seven chapters on various designs for microstrip patches, and …